Iloprost (5 µg) ( DrugBank: Iloprost )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
86	Pulmonary arterial hypertension	2

86. Pulmonary arterial hypertension

---

Clinical trials : 1,205 /  Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00709956 (ClinicalTrials.gov)	July 2008	1/7/2008	Iloprost Power 15 in Pulmonary Arterial Hypertension	A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension	Pulmonary Arterial Hypertension	Drug: iloprost (5 µg);Drug: placebo	Actelion	NULL	Completed	18 Years	N/A	All	64	Phase 3	United States;Austria;Germany
2	NCT00302211 (ClinicalTrials.gov)	February 1, 2006	10/3/2006	The VISION Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension	A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of the Addition of Inhaled Iloprost in Patients With Pulmonary Arterial Hypertension Receiving Oral Sildenafil	Pulmonary Hypertension	Drug: Inhaled Iloprost (5 µg);Drug: Inhaled Placebo;Drug: Sildenafil;Drug: Bosentan	Actelion	NULL	Terminated	12 Years	85 Years	All	67	Phase 3	United States